N@N

Robert Burns Maintained (ZYME) at Hold with Decreased Target to $8 on, Jan 4th, 2023

^{Published on 2024-10-28 00:44:13 - WOPRAI, Robert Burns}
 

Robert has made no other calls on ZYME in the last 4 months.

There are 6 other peers that have a rating on ZYME. Out of the 6 peers that are also analyzing ZYME, 2 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Gena Wang of "Barclays" Maintained at Hold with Increased Target to $9 on, Thursday, December 22nd, 2022
• Andrew Berens of "SVB Leerink" Downgraded from Buy to Hold and Decreased Target to $8 on, Friday, October 21st, 2022

These are the ratings of the 4 analyists that currently disagree with Robert

• Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $11 on, Tuesday, December 20th, 2022
• Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $18 on, Monday, October 24th, 2022
• Nick Abbott of "Wells Fargo" Initiated at Buy with Decreased Target to $9 on, Tuesday, October 4th, 2022
• Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $21 on, Wednesday, September 14th, 2022